Fortress Biotech Inc (FBIO)
1.605
+0.04
(+2.23%)
USD |
NASDAQ |
Nov 22, 16:00
1.605
0.00 (0.00%)
After-Hours: 19:14
Fortress Biotech Profit Margin (Quarterly): -87.96% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -87.96% |
| June 30, 2024 | -73.50% |
| March 31, 2024 | -118.3% |
| December 31, 2023 | -46.52% |
| September 30, 2023 | -14.52% |
| June 30, 2023 | -142.5% |
| March 31, 2023 | -173.3% |
| December 31, 2022 | -164.3% |
| September 30, 2022 | -136.2% |
| June 30, 2022 | -113.1% |
| March 31, 2022 | -65.87% |
| December 31, 2021 | -172.7% |
| September 30, 2021 | -98.56% |
| June 30, 2021 | -19.81% |
| March 31, 2021 | -76.14% |
| December 31, 2020 | -38.51% |
| September 30, 2020 | -164.1% |
| June 30, 2020 | -140.8% |
| March 31, 2020 | -95.76% |
| December 31, 2019 | -139.2% |
| Date | Value |
|---|---|
| September 30, 2019 | -130.6% |
| June 30, 2019 | -141.6% |
| March 31, 2019 | 21.49% |
| December 31, 2018 | -276.7% |
| September 30, 2018 | -321.6% |
| June 30, 2018 | -317.1% |
| March 31, 2018 | -356.1% |
| December 31, 2017 | 8.33% |
| September 30, 2017 | -57.83% |
| June 30, 2017 | -34.25% |
| March 31, 2017 | -26.82% |
| December 31, 2016 | -138.2% |
| September 30, 2016 | -1.33K% |
| June 30, 2016 | -559.6% |
| March 31, 2016 | -1.85K% |
| December 31, 2015 | -3.56K% |
| September 30, 2015 | -72.64K% |
| June 30, 2015 | |
| March 31, 2015 | -2.41K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-173.3%
Minimum
Mar 2023
-14.52%
Maximum
Sep 2023
-104.1%
Average
-105.8%
Median
Profit Margin (Quarterly) Benchmarks
| Journey Medical Corp | -16.34% |
| Checkpoint Therapeutics Inc | -- |
| Avenue Therapeutics Inc | -- |
| Mustang Bio Inc | -- |
| NovaBay Pharmaceuticals Inc | -49.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -32.11% |
| Return on Invested Capital | -94.06% |
| Gross Profit Margin (Quarterly) | 63.87% |
| Operating Margin (Quarterly) | -151.0% |
| Return on Net Operating Assets | -77.74% |